Work

Abstract 108: Impact of a Wireless "Wearable" Device to Measure Daily Activity in Patients With Coronary Microvascular Disease Treated With Late Na Channel Inhibition (ranolazine): a Substudy of the RWISE Clinical Trial

Year: 2017

Type: conference-abstract

Source: Circulation Cardiovascular Quality and Outcomes

DOI: 10.1161/circoutcomes.10.suppl_3.108

Authors: Kade Birkeland, Raj M Khandwalla, Ilan Kedan, Chrisandra L Shufelt, Puja K Mehta, Margo B Minissian, Janet Wei, Eileen M Handberg, Louise E Thomson, Daniel S Berman, John W Petersen, R. D Anderson, Galen Cook-Wiens, Carl J Pepine, C N Bairey Merz

Institutions: Cedars-Sinai Medical Center, Cedars-Sinai Smidt Heart Institute, Emory University, University of Florida, S. Mark Taper Foundation

Language: English

Topic: Heart rate and cardiovascular health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2606486618

Cites:

Cited by:

Related to: 10